Beyond hepatocellular carcinoma and colorectal metastasis: The expanding applications of radioembolization

Frontiers in Oncology

Volumn 4 JUN, Issue , 2014, Pages

  Zurkiya, Omar ^a   Ganguli, Suvranu ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Breast radioembolization; Melanoma radioembolization; Metastatic liver radioembolization; Neuroendocrine radioembolization; Radioembolization

Indexed keywords

ARTIFICIAL EMBOLISM; BREAST METASTASIS; CHEMOEMBOLIZATION; HUMAN; IATROGENIC DISEASE; LIVER CELL CARCINOMA; LIVER METASTASIS; METASTATIC COLORECTAL CANCER; NEUROENDOCRINE TUMOR; PRIMARY TUMOR; RADIOEMBOLIZATION; REVIEW; UVEA MELANOMA; Y 90 RADIOEMBOLIZATION;

EID: 84904693927     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00150     Document Type: Review

References (21)

1. Yang TX, Chua TC, Morris DL. Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review. Surg Oncol (2012) 21(4):299-308. doi: 10.1016/j.suronc.2012.07.001
2. Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, et al. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 20(7 Suppl):S425-34. doi:10.1016/j.jvir.2009.04.021
3. King J, Quinn R, Glenn DM, Janssen J, Tong D, Liaw W, et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer (2008) 113(5):921-9. doi:10.1002/cncr.23685
4. Murthy R, Kamat P, Nunez R, Madoff DC, Gupta S, Salem R, et al. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol (2008) 19(1):145-51. doi:10.1016/j.jvir.2007.09.006
5. Rhee TK, Lewandowski RJ, Liu DM, Mulcahy MF, Takahashi G, Hansen PD, et al. 90Y radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg (2008) 247(6):1029-35. doi:10.1097/SLA.0b013e3181728a45
6. Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer (2014) 120(9):1290-314. doi:10.1002/cncr.28509
7. Eichbaum MH, Kaltwasser M, Bruckner T, de Rossi TM, Schneeweiss A, Sohn C. Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res Treat (2006) 96(1):53-62. doi:10.1007/s10549-005-9039-1
8. Saxena A, Kapoor J, Meteling B, Morris DL, Bester L. Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients. Ann Surg Oncol (2013) 21(4):1296-303. doi:10.1245/s10434-013-3436-1
9. Smits ML, Prince JF, Rosenbaum CE, van den Hoven AF, Nijsen JF, Zonnenberg BA, et al. Intra-arterial radioembolization of breast cancer liver metastases: a structured review. Eur J Pharmacol (2013) 709(1-3):37-42. doi:10.1016/j.ejphar.2012.11.067
10. Wyld L, Gutteridge E, Pinder SE, James JJ, Chan SY, Cheung KL, et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer (2003) 89(2):284-90. doi:10.1038/sj.bjc.6601038
11. Kennedy AS, Nutting C, Jakobs T, Cianni R, Notarianni E, Ofer A, et al. A first report of radioembolization for hepatic metastases from ocular melanoma. Cancer Invest (2009) 27(6):682-90. doi:10.1080/07357900802620893
12. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group report no. 26. Arch Ophthalmol (2005) 123(12):1639-43. doi:10.1001/archopht.123.12.1639
13. Gonsalves CF, Eschelman DJ, Sullivan KL, Anne PR, Doyle L, Sato T. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience. AJR Am J Roentgenol (2011) 196(2):468-73. doi:10.2214/AJR.10.4881
14. Dhanasekaran R, Khanna V, Lawson D, Delman KA, Kim HS, editors. Survival benefits of yttrium-90 radioembolization (SIR-spheres) for Hepatic Metastasis from melanoma: preliminary study. SIR Annual Scientific Meeting. San Diego, CA: Elsevier (2009).
15. Klingenstein A, Haug AR, Zech CJ, Schaller UC. Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients. Cardiovasc Intervent Radiol (2013) 36(1):158-65. doi:10.1007/s00270-012-0373-5
16. Stuart JE, Tan B, Myerson RJ, Garcia-Ramirez J, Goddu SM, Pilgram TK, et al. Salvage radioembolization of liver-dominant metastases with a resin-based microsphere: initial outcomes. J Vasc Interv Radiol (2008) 19(10):1427-33. doi:10.1016/j.jvir.2008.07.009
17. Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, et al. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres - safety, efficacy, and survival. Radiology (2008) 247(2):507-15. doi:10.1148/radiol.2472062029
18. Coldwell DM, Kennedy AS, Nutting CW. Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int J Radiat Oncol Biol Phys (2007) 69(3):800-4. doi:10.1016/j.ijrobp.2007.03.056
19. Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, et al. Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol (2008) 19(5):683-90. doi:10.1016/j.jvir.2008.01.009
20. Hamoui N, Gates VL, Gonzalez J, Lewandowski RJ, Salem R. Radioembolization of renal cell carcinoma using yttrium-90 microspheres. J Vasc Interv Radiol (2013) 24(2):298-300. doi:10.1016/j.jvir.2012.10.027
21. Ricke J, Groβer O, Amthauer H. Y90-radioembolization of lung metastases via the bronchial artery: a report of 2 cases. Cardiovasc Intervent Radiol (2013) 36(6):1664-9. doi:10.1007/s00270-013-0690-3